Cargando…

Dexamethasone intravitreal implant in diabetic macular oedema refractory to anti-vascular endothelial growth factors: the AUSSIEDEX study

AIM: To evaluate effectiveness of dexamethasone intravitreal implant 0.7 mg (DEX) monotherapy in the AUSSIEDEX study non-responder subgroup, defined by diabetic macular oedema (DME) refractory to anti-vascular endothelial growth factor (anti-VEGF) agents. METHODS: This prospective, open-label, obser...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mitchell, Paul, Arnold, Jennifer, Fraser-Bell, Samantha, Kang, Hyong Kwon, Chang, Andrew A, Tainton, Jodi, Simonyi, Susan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Retina
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407411/ https://www.ncbi.nlm.nih.gov/pubmed/37541745 http://dx.doi.org/10.1136/bmjophth-2022-001224

Ejemplares similares

Dexamethasone intravitreal implant in treatment-naïve diabetic macular oedema: findings from the prospective, multicentre, AUSSIEDEX study
por: Fraser-Bell, Samantha, et al.
Publicado: (2023)

Comparing vision and macular thickness in neovascular age-related macular degeneration, diabetic macular oedema and retinal vein occlusion patients treated with intravitreal antivascular endothelial growth factor injections in clinical practice
por: Gurung, Rajya L, et al.
Publicado: (2021)

Controlled Release of Dexamethasone From an Intravitreal Delivery System Using Porous Silicon Dioxide
por: Hou, Huiyuan, et al.
Publicado: (2016)

Turnover of Microaneurysms After Intravitreal Injections of Faricimab for Diabetic Macular Edema
por: Takamura, Yoshihiro, et al.
Publicado: (2023)

Serum apolipoprotein A1 and B are associated with 6-month persistent and incident diabetic macular oedema in type 2 diabetes
por: Soedarman, Soefiandi, et al.
Publicado: (2023)

Intravitreal anti-vascular endothelial growth factor for the treatment of chronic central serous retinopathy: a meta-analysis of the literature
por: Palakkamanil, Mathew, et al.
Publicado: (2023)

Quantifying burden of intravitreal injections: questionnaire assessment of life impact of treatment by intravitreal injections (QUALITII)
por: Wang, Rui, et al.
Publicado: (2022)

Macular Oedema Related to Idiopathic Macular Telangiectasia Type 1 Treated with Dexamethasone Intravitreal Implant (Ozurdex)
por: Loutfi, Mohamed, et al.
Publicado: (2014)

Intravitreal dexamethasone implant for the treatment of cystoid macular oedema associated with acute retinal necrosis
por: Majumder, Parthopratim Dutta, et al.
Publicado: (2016)

Change in choroidal volume after dexamethasone intravitreal implant in eyes with diabetic macular oedema
por: Posch‐Pertl, Laura, et al.
Publicado: (2018)

Real Life Experience of Dexamethasone Implant in Refractory Diabetic Macular Oedema
por: Karttunen, Tommi, et al.
Publicado: (2019)

Healthcare expenditure of intravitreal anti‐vascular endothelial growth factor inhibitors compared with dexamethasone implant for diabetic macular oedema
por: Hertzberg, Silvia NW, et al.
Publicado: (2022)

Associations with sight-threatening diabetic macular oedema among Indigenous adults with type 2 diabetes attending an Indigenous primary care clinic in remote Australia: a Centre of Research Excellence in Diabetic Retinopathy and Telehealth Eye and Associated Medical Services Network study
por: Brazionis, Laima, et al.
Publicado: (2021)

Active Transport and Ocular Distribution of Intravitreally Injected Liposomes
por: Eriksen, Anne Zebitz, et al.
Publicado: (2023)

Extended Intravitreal Rabbit Eye Residence of Nanoparticles Conjugated With Cationic Arginine Peptides for Intraocular Drug Delivery: In Vivo Imaging
por: Melgar-Asensio, Ignacio, et al.
Publicado: (2018)

Questionnaire to Assess Life Impact of Treatment by Intravitreal Injections (QUALITII): Development of a patient-reported measure to assess treatment burden of repeat intravitreal injections
por: McClard, Cynthia K, et al.
Publicado: (2021)

Three-Dimensional Transport Model for Intravitreal and Suprachoroidal Drug Injection
por: Zhang, Yu, et al.
Publicado: (2018)

Intravitreal Fluocinolone Acetonide May Decelerate Diabetic Retinal Neurodegeneration
por: Lynch, Stephanie K., et al.
Publicado: (2019)

Real world evidence on 5661 patients treated for macular oedema secondary to branch retinal vein occlusion with intravitreal anti-vascular endothelial growth factor, intravitreal dexamethasone or macular laser
por: Gale, Richard, et al.
Publicado: (2021)

The Carnitine Shuttle Pathway is Altered in Patients With Neovascular Age-Related Macular Degeneration
por: Mitchell, Sabrina L., et al.
Publicado: (2018)

Hemodynamic Effects of Anti-Vascular Endothelial Growth Factor Injections on Optical Coherence Tomography Angiography in Diabetic Macular Edema Eyes
por: Song, Jessica, et al.
Publicado: (2022)

Acuity and colour vision changes post intravitreal dexamethasone implant injection in patients with diabetic macular oedema
por: Abdel-Hay, Ahmed, et al.
Publicado: (2018)

Optical Coherence Tomography Angiography Quantitative Assessment of Macular Neovascularization in Best Vitelliform Macular Dystrophy
por: Battaglia Parodi, Maurizio, et al.
Publicado: (2020)

Choriocapillaris Flow Deficits and Treatment-Naïve Macular Neovascularization Secondary to Age-Related Macular Degeneration
por: Scharf, Jackson M., et al.
Publicado: (2020)

Randomized Trial of Treat-and-Extend Intravitreal Aflibercept for Radiation Retinopathy: 1-Year Outcomes
por: Trejo Corona, Stephanie, et al.
Publicado: (2023)

Decreased Macular Choriocapillaris Perfusion in Eyes With Macular Reticular Pseudodrusen Imaged With Swept-Source OCT Angiography
por: Li, Jianqing, et al.
Publicado: (2023)

Ten-year real-world outcomes of antivascular endothelial growth factor therapy in neovascular age-related macular degeneration using pro re nata regimen
por: Hujanen, Pekko, et al.
Publicado: (2023)

Aflibercept in Diabetic Macular Oedema Previously Refractory to Standard Intravitreal Therapy: An Irish Retrospective Study
por: McCloskey, Clare F., et al.
Publicado: (2018)

Hyperreflective Stress Lines and Macular Holes
por: Scharf, Jackson M., et al.
Publicado: (2020)

Macular Thickness in Intermediate Age-Related Macular Degeneration Is Influenced by Disease Severity and Subretinal Drusenoid Deposit Presence
por: Chiang, Trent Tsun-Kang, et al.
Publicado: (2020)

Vitreous Fatty Amides and Acyl Carnitines Are Altered in Intermediate Age-Related Macular Degeneration
por: Yoon, Chang-Ki, et al.
Publicado: (2023)

Intravitreal Dexamethasone Implants for Refractory Macular Edema in Eyes with Noninfectious Uveitis
por: Kang, Eugene Yu-Chuan, et al.
Publicado: (2021)

Local Abundance of Macular Xanthophyll Pigment Is Associated with Rod- and Cone-Mediated Vision in Aging and Age-Related Macular Degeneration
por: Kar, Deepayan, et al.
Publicado: (2020)

Cluster of symptomatic silicone oil droplets following intravitreal injections: a 1-year observational study
por: Sivertsen, Magne Sand, et al.
Publicado: (2021)

Multimodal Imaging in Best Vitelliform Macular Dystrophy
por: Lima de Carvalho, Jose Ronaldo, et al.
Publicado: (2019)

Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO) of Macular Pigment
por: Sauer, Lydia, et al.
Publicado: (2018)

Pathophysiology of Secondary Macular Hole in Rhegmatogenous Retinal Detachment
por: Martins Melo, Isabela, et al.
Publicado: (2023)

Intravitreal AAV2.COMP-Ang1 Attenuates Deep Capillary Plexus Expansion in the Aged Diabetic Mouse Retina
por: Carroll, Lara S., et al.
Publicado: (2019)

Intravitreal Short-Hairpin RNA Attenuated Adeno-Associated Virus–Induced Knockdown of Amphiregulin and Axial Elongation in Experimental Myopia
por: Dong, Li, et al.
Publicado: (2023)

Intravitreal Administration of AAV2-SIRT1 Reverses Diabetic Retinopathy in a Mouse Model of Type 2 Diabetes
por: Adu-Agyeiwaah, Yvonne, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_us6lktis12gc22q6djgmfejmoc